257 related articles for article (PubMed ID: 34609093)
1. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
Chun JY; Jeong H; Kim Y
J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
[TBL] [Abstract][Full Text] [Related]
2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
Wong RSY
Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
[TBL] [Abstract][Full Text] [Related]
4. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
5. Herd immunization with childhood vaccination may provide protection against COVID-19.
Yu Y
Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
[TBL] [Abstract][Full Text] [Related]
6. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
7. Five reasons why COVID herd immunity is probably impossible.
Aschwanden C
Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753
[No Abstract] [Full Text] [Related]
8. On reaching herd immunity during the COVID-19 pandemic and further issues.
Pandolfi S; Chirumbolo S
J Med Virol; 2022 Jan; 94(1):24-25. PubMed ID: 34491592
[No Abstract] [Full Text] [Related]
9. Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination.
Shin DH; Oh HS; Jang H; Lee S; Choi BS; Kim D
J Korean Med Sci; 2022 Jan; 37(3):e23. PubMed ID: 35040298
[TBL] [Abstract][Full Text] [Related]
10. Estimating contact-adjusted immunity levels against measles in South Korea and prospects for maintaining elimination status.
Chun JY; Park WB; Kim NJ; Choi EH; Funk S; Oh MD
Vaccine; 2020 Jan; 38(2):107-111. PubMed ID: 31679860
[TBL] [Abstract][Full Text] [Related]
11. [Immunity against SARS-CoV-2: walking to the vaccination].
RodrÃguez Hernández C; Sanz Moreno L
Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
[TBL] [Abstract][Full Text] [Related]
12. Herd immunity: challenges and the way forward in Korea.
Oh J; Kim S; Ryu B; Shin M; Kim BI
Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
[TBL] [Abstract][Full Text] [Related]
13. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
Veldhoen M; Simas JP
Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
[TBL] [Abstract][Full Text] [Related]
14. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
Voigt A; Omholt S; Almaas E
PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
[TBL] [Abstract][Full Text] [Related]
15. Herd Immunity to COVID-19.
Kadkhoda K
Am J Clin Pathol; 2021 Mar; 155(4):471-472. PubMed ID: 33399182
[No Abstract] [Full Text] [Related]
16. Are COVID vaccination programmes working? Scientists seek first clues.
Mallapaty S
Nature; 2021 Jan; 589(7843):504-505. PubMed ID: 33483685
[No Abstract] [Full Text] [Related]
17. COVID-19 and immunity: quo vadis?
Miyasaka M
Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
[TBL] [Abstract][Full Text] [Related]
18. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
[TBL] [Abstract][Full Text] [Related]
19. Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.
Yewdell JW
PLoS Pathog; 2021 Apr; 17(4):e1009509. PubMed ID: 33901246
[No Abstract] [Full Text] [Related]
20. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
